all the information, none of the junk | biotech • healthcare • life sciences

Wave Life Sciences Taps Shire Finance Exec as CFO

Xconomy Boston — 

Cambridge, MA-based RNA drug developer Wave Life Sciences (NASDAQ: WVE) has named Keith Regnante its chief financial officer. Regnante was previously the VP of finance at Shire, and had stints at Biogen and Boston Consulting Group before that.